Distinct dual antiviral mechanism that enhances hepatitis B virus mutagenesis and reduces viral DNA synthesis

Keyphrases

• Antiviral Activity 100%
• Mutagenesis 100%
• Hepatitis B Virus 100%
• Viral DNA Synthesis 100%
• Viral 83%
• Circulating Tumor DNA (ctDNA) 83%
• Mutagens 83%
• 5-Aza-dC 50%
• Retrovirus 33%
• Reverse Transcription 33%
• 5-azacytidine 33%
• Hepatitis B Virus Replication 33%
• Plasmid 16%
• Virus Infection 16%
• Host Cell 16%
• Viral Replication 16%
• Virion 16%
• DNA Synthesis 16%
• Episome 16%
• Current Therapies 16%
• Reverse Transcriptase 16%
• Viral mutagenesis 16%
• Mutation Frequency 16%
• Reporter Gene 16%
• Gap Region 16%
• Replication Intermediates 16%
• Nucleoside Analogues 16%
• Virus Vector 16%
• Cell nucleus 16%
• DNA Genome 16%
• Can Effect 16%
• Essential Enzymes 16%
• Transversion mutations 16%
• 5-aza-2′-deoxycytidine 16%
• Virus Transfer 16%
• Relaxed Circular DNA 16%
• Covalently Closed Circular DNA 16%
• Hepadnavirus 16%

Immunology and Microbiology

• Hepatitis B Virus 100%
• DNA Synthesis 100%
• Mutagenesis 100%
• DNA Virus 100%
• Viral Replication 37%
• Reverse Transcription 25%
• Retrovirus 25%
• Reporter Gene 12%
• Viral Vector 12%
• Host Cell 12%
• Plasmid 12%
• Mutation Rate 12%
• Virion 12%
• Episome 12%
• Target Cell 12%
• Hepadnaviridae 12%
• Reverse Transcriptase 12%
• Cell Nucleus 12%